Skip to main content
Top
Published in: European Archives of Oto-Rhino-Laryngology 11/2012

01-11-2012 | Laryngology

Transmission of human papillomavirus DNA from patient to surgical masks, gloves and oral mucosa of medical personnel during treatment of laryngeal papillomas and genital warts

Authors: Taru Ilmarinen, Eeva Auvinen, Eija Hiltunen-Back, Annamari Ranki, Leena-Maija Aaltonen, Anne Pitkäranta

Published in: European Archives of Oto-Rhino-Laryngology | Issue 11/2012

Login to get access

Abstract

The risk of occupational human papillomavirus (HPV) transmission from patient to medical personnel during laser vaporization procedures remains controversial. The purpose of this study was to determine the risk of HPV transmission from the patient to the protective surgical masks, gloves and oral mucosa of medical personnel during the treatment of laryngeal papillomas and genital warts. The study involved five male patients scheduled for the surgical treatment of laryngeal papillomas, and five male patients undergoing carbon dioxide (CO2) laser treatment for urethral warts. Oral mucosa specimens were obtained from the study patients and the employees pre- and postoperatively. Samples were collected from the HPV-infected patient tissue, and from the surgical masks and gloves used by the employees. A total of 120 samples were analyzed for the presence of HPV DNA by PCR, using the degenerated MY09/11/HMB01 primers. After the papilloma procedures, the surgeons’ gloves tested HPV positive in one of the five cases and those of the surgical nurse in three of the five cases. After the treatment of genital warts, HPV DNA corresponding to the patient tissue specimens was present in all the samples obtained from the surgical gloves of the operators. All oral mucosa samples obtained from 18 different employees tested HPV negative, as did the surgical mask specimens. According to our study, HPV may contaminate protective equipment, most of all surgical gloves, but transmission of HPV DNA to medical personnel is unlikely to occur provided that protective surgical gloves and masks are applied and disposed of properly.
Literature
1.
go back to reference Aaltonen LM, Rihkanen H, Vaheri A (2002) Human papillomavirus in larynx. Laryngoscope 112:700–707PubMedCrossRef Aaltonen LM, Rihkanen H, Vaheri A (2002) Human papillomavirus in larynx. Laryngoscope 112:700–707PubMedCrossRef
2.
go back to reference Partridge JM, Koutsky LA (2006) Genital human papillomavirus infection in men. Lancet Infect Dis 6:21–31PubMedCrossRef Partridge JM, Koutsky LA (2006) Genital human papillomavirus infection in men. Lancet Infect Dis 6:21–31PubMedCrossRef
3.
go back to reference Syrjanen S (2010) Current concepts on human papillomavirus infections in children. APMIS 118:494–509PubMedCrossRef Syrjanen S (2010) Current concepts on human papillomavirus infections in children. APMIS 118:494–509PubMedCrossRef
4.
go back to reference Viera MH, Amini S, Huo R, Konda S, Block S, Berman B (2010) Herpes simplex virus and human papillomavirus genital infections: New and investigational therapeutic options. Int J Dermatol 49:733–749PubMed Viera MH, Amini S, Huo R, Konda S, Block S, Berman B (2010) Herpes simplex virus and human papillomavirus genital infections: New and investigational therapeutic options. Int J Dermatol 49:733–749PubMed
5.
go back to reference Dedo HH, Yu KC (2001) CO(2) laser treatment in 244 patients with respiratory papillomas. Laryngoscope 111:1639–1644PubMedCrossRef Dedo HH, Yu KC (2001) CO(2) laser treatment in 244 patients with respiratory papillomas. Laryngoscope 111:1639–1644PubMedCrossRef
6.
go back to reference Garden JM, O’Banion MK, Shelnitz LS et al (1988) Papillomavirus in the vapor of carbon dioxide laser-treated verrucae. JAMA 259:1199–1202PubMedCrossRef Garden JM, O’Banion MK, Shelnitz LS et al (1988) Papillomavirus in the vapor of carbon dioxide laser-treated verrucae. JAMA 259:1199–1202PubMedCrossRef
7.
go back to reference Kashima HK, Kessis T, Mounts P, Shah K (1991) Polymerase chain reaction identification of human papillomavirus DNA in CO2 laser plume from recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg 104:191–195PubMed Kashima HK, Kessis T, Mounts P, Shah K (1991) Polymerase chain reaction identification of human papillomavirus DNA in CO2 laser plume from recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg 104:191–195PubMed
8.
go back to reference Hallmo P, Naess O (1991) Laryngeal papillomatosis with human papillomavirus DNA contracted by a laser surgeon. Eur Arch Otorhinolaryngol 248:425–427PubMedCrossRef Hallmo P, Naess O (1991) Laryngeal papillomatosis with human papillomavirus DNA contracted by a laser surgeon. Eur Arch Otorhinolaryngol 248:425–427PubMedCrossRef
9.
go back to reference Calero L, Brusis T (2003) Laryngeal papillomatosis—first recognition in Germany as an occupational disease in an operating room nurse. Laryngorhinootologie 82:790–793PubMedCrossRef Calero L, Brusis T (2003) Laryngeal papillomatosis—first recognition in Germany as an occupational disease in an operating room nurse. Laryngorhinootologie 82:790–793PubMedCrossRef
10.
go back to reference Ferenczy A, Bergeron C, Richart RM (1990) Carbon dioxide laser energy disperses human papillomavirus deoxyribonucleic acid onto treatment fields. Am J Obstet Gynecol 163:1271–1274PubMed Ferenczy A, Bergeron C, Richart RM (1990) Carbon dioxide laser energy disperses human papillomavirus deoxyribonucleic acid onto treatment fields. Am J Obstet Gynecol 163:1271–1274PubMed
11.
go back to reference Sawchuk WS, Weber PJ, Lowy DR, Dzubow LM (1989) Infectious papillomavirus in the vapor of warts treated with carbon dioxide laser or electrocoagulation: Detection and protection. J Am Acad Dermatol 21:41–49PubMedCrossRef Sawchuk WS, Weber PJ, Lowy DR, Dzubow LM (1989) Infectious papillomavirus in the vapor of warts treated with carbon dioxide laser or electrocoagulation: Detection and protection. J Am Acad Dermatol 21:41–49PubMedCrossRef
12.
go back to reference Nori S, Greene MA, Schrager HM, Falanga V (2005) Infectious occupational exposures in dermatology—a review of risks and prevention measures. I. for all dermatologists. J Am Acad Dermatol 53:1010–1019PubMedCrossRef Nori S, Greene MA, Schrager HM, Falanga V (2005) Infectious occupational exposures in dermatology—a review of risks and prevention measures. I. for all dermatologists. J Am Acad Dermatol 53:1010–1019PubMedCrossRef
13.
go back to reference Saiki RK, Scharf S, Faloona F et al (1985) Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230:1350–1354PubMedCrossRef Saiki RK, Scharf S, Faloona F et al (1985) Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230:1350–1354PubMedCrossRef
14.
go back to reference Hildesheim A, Schiffman MH, Gravitt PE et al (1994) Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 169:235–240PubMedCrossRef Hildesheim A, Schiffman MH, Gravitt PE et al (1994) Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 169:235–240PubMedCrossRef
15.
go back to reference Meyer T, Arndt R, Stockfleth E, Flammann HT, Wolf H, Reischl U (1995) Strategy for typing human papillomaviruses by RFLP analysis of PCR products and subsequent hybridization with a generic probe. Biotechniques 19:632–639PubMed Meyer T, Arndt R, Stockfleth E, Flammann HT, Wolf H, Reischl U (1995) Strategy for typing human papillomaviruses by RFLP analysis of PCR products and subsequent hybridization with a generic probe. Biotechniques 19:632–639PubMed
16.
go back to reference Dunne EF, Unger ER, Sternberg M et al (2007) Prevalence of HPV infection among females in the United States. JAMA 297:813–819PubMedCrossRef Dunne EF, Unger ER, Sternberg M et al (2007) Prevalence of HPV infection among females in the United States. JAMA 297:813–819PubMedCrossRef
17.
go back to reference Munoz N, Castellsague X, de Gonzalez AB, Gissmann L (2006) Chapter 1: HPV in the etiology of human cancer. Vaccine 24 Suppl 3:S3/1–10 Munoz N, Castellsague X, de Gonzalez AB, Gissmann L (2006) Chapter 1: HPV in the etiology of human cancer. Vaccine 24 Suppl 3:S3/1–10
18.
go back to reference Anic GM, Lee JH, Stockwell H et al (2011) Incidence and human papillomavirus (HPV) type distribution of genital warts in a multinational cohort of men: the HPV in men study. J Infect Dis 204:1886–1892PubMedCrossRef Anic GM, Lee JH, Stockwell H et al (2011) Incidence and human papillomavirus (HPV) type distribution of genital warts in a multinational cohort of men: the HPV in men study. J Infect Dis 204:1886–1892PubMedCrossRef
19.
go back to reference Ball SL, Winder DM, Vaughan K et al (2011) Analyses of human papillomavirus genotypes and viral loads in anogenital warts. J Med Virol 83:1345–1350PubMedCrossRef Ball SL, Winder DM, Vaughan K et al (2011) Analyses of human papillomavirus genotypes and viral loads in anogenital warts. J Med Virol 83:1345–1350PubMedCrossRef
20.
go back to reference Weyandt GH, Tollmann F, Kristen P, Weissbrich B (2011) Low risk of contamination with human papilloma virus during treatment of condylomata acuminata with multilayer argon plasma coagulation and CO laser ablation. Arch Dermatol Res 303:141–144PubMedCrossRef Weyandt GH, Tollmann F, Kristen P, Weissbrich B (2011) Low risk of contamination with human papilloma virus during treatment of condylomata acuminata with multilayer argon plasma coagulation and CO laser ablation. Arch Dermatol Res 303:141–144PubMedCrossRef
21.
go back to reference Bergbrant IM, Samuelsson L, Olofsson S, Jonassen F, Ricksten A (1994) Polymerase chain reaction for monitoring human papillomavirus contamination of medical personnel during treatment of genital warts with CO2 laser and electrocoagulation. Acta Derm Venereol 74:393–395PubMed Bergbrant IM, Samuelsson L, Olofsson S, Jonassen F, Ricksten A (1994) Polymerase chain reaction for monitoring human papillomavirus contamination of medical personnel during treatment of genital warts with CO2 laser and electrocoagulation. Acta Derm Venereol 74:393–395PubMed
22.
go back to reference Hughes PS, Hughes AP (1998) Absence of human papillomavirus DNA in the plume of erbium:YAG laser-treated warts. J Am Acad Dermatol 38:426–428PubMedCrossRef Hughes PS, Hughes AP (1998) Absence of human papillomavirus DNA in the plume of erbium:YAG laser-treated warts. J Am Acad Dermatol 38:426–428PubMedCrossRef
23.
go back to reference Sawchuk WS, Weber PJ, Lowy DR, Dzubow LM (1989) Infectious papillomavirus in the vapor of warts treated with carbon dioxide laser or electrocoagulation: detection and protection. J Am Acad Dermatol 21:41–49PubMedCrossRef Sawchuk WS, Weber PJ, Lowy DR, Dzubow LM (1989) Infectious papillomavirus in the vapor of warts treated with carbon dioxide laser or electrocoagulation: detection and protection. J Am Acad Dermatol 21:41–49PubMedCrossRef
24.
go back to reference Gloster HM Jr, Roenigk RK (1995) Risk of acquiring human papillomavirus from the plume produced by the carbon dioxide laser in the treatment of warts. J Am Acad Dermatol 32:436–441PubMedCrossRef Gloster HM Jr, Roenigk RK (1995) Risk of acquiring human papillomavirus from the plume produced by the carbon dioxide laser in the treatment of warts. J Am Acad Dermatol 32:436–441PubMedCrossRef
25.
go back to reference Bellina JH, Stjernholm RL, Kurpel JE (1982) Analysis of plume emissions after papovavirus irradiation with the carbon dioxide laser. J Reprod Med 27:268–270PubMed Bellina JH, Stjernholm RL, Kurpel JE (1982) Analysis of plume emissions after papovavirus irradiation with the carbon dioxide laser. J Reprod Med 27:268–270PubMed
26.
go back to reference Manos MM, Ting Y, Wright DK et al (1989) Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7:209–214 Manos MM, Ting Y, Wright DK et al (1989) Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7:209–214
27.
go back to reference Bernard HU, Chan SY, Manos MM et al (1994) Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 170:1077–1085PubMedCrossRef Bernard HU, Chan SY, Manos MM et al (1994) Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 170:1077–1085PubMedCrossRef
Metadata
Title
Transmission of human papillomavirus DNA from patient to surgical masks, gloves and oral mucosa of medical personnel during treatment of laryngeal papillomas and genital warts
Authors
Taru Ilmarinen
Eeva Auvinen
Eija Hiltunen-Back
Annamari Ranki
Leena-Maija Aaltonen
Anne Pitkäranta
Publication date
01-11-2012
Publisher
Springer-Verlag
Published in
European Archives of Oto-Rhino-Laryngology / Issue 11/2012
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-012-2049-9

Other articles of this Issue 11/2012

European Archives of Oto-Rhino-Laryngology 11/2012 Go to the issue